STOCKS TELEGRAPH

Tag: Tonix Pharmaceuticals Holding Corp.

  • Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Losing Momentum in Premarket, What’s Happening.

    Tonix Pharmaceuticals Holding Corp. (TNXP) is a leading global biotherapeutics company focused on the development of therapeutics for different unmet medical conditions. The company’s leading product portfolio includes TNX-1800 used as a COVID-19 vaccine. TNX-3500 and TNX-102 SL are also under the clinical trial stage for the treatment of COVID-19. TNX-102 SL is in Phase 3 clinical trial for treating fibromyalgia and TNX-1300 for cocaine intoxication.

    The price of TNXP stock during regular trading on March 3, 2022, was $0.25 with a surge of 33.07%. At last check in the premarket on March 4, 2022, its price plunged by 7.98%.

    TNXP: Events and Happenings

    On March 03, 2022, TNXP reported the grant of Orphan-Drug Designation by the FDA to TNX-2900 used in treating Prader-Willi syndrome. On February 28, 2022, TNXP updated on its entry into a research contract with Inserm Transfert. Both the companies agreed upon studying oxytocin levels in the mouse model for Prader-Willi syndrome.

    On February 07, 2022, TNXP announced its Executive management’s participation at the Virtual BIO CEO & Investor Conference held on February 14-17, 2022. On January 11, 2022, TNXP informed the press about the initial patient enrollment in dose-finding trials for TNX-2100. It is used to measure delayed-type hypersensitivity to SARS-CoV-2.

    On January 05, 2022, TNXP updated on its management’s presentation at the following conferences.

    • Virtual H.C. Wainwright BioConnect Conference held on January 10-13, 2022, and
    • The Biotech Virtual Showcase 2022 was held on January 10-12 & 17-19, 2022.

    TNXP: Key Financials

    On November 8, 2021, TNXP released its unaudited financial outcomes for the third quarter ended September 30, 2021. Some of the main features are discussed here.

    Revenue

    No revenue was recorded in the third quarter of 2021 as in the same quarter of 2020.

    EPS

    Net loss per basic and diluted share in the third quarter of 2021 was $18.5 million or $0.05 comparable to $11.9 million or $0.09 in the same quarter of 2020. The company’s EPS topped the analysts’ estimates by $0.02.

    Conclusion

    TNXP stock is 73% low from the past year as a result of the pandemic. Currently, the company is working tirelessly to prove itself as a leading biotech company as its stock swelled in Thursday’s regular trading after it announced ODD to its lead candidate by the FDA. In Friday’s premarket session, the company’s stock declined gradually to shed its yesterday’s gain. The fourth-quarter earnings release date is also approaching and the company expects an EPS of -$0.06.

  • Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Plummeting in Premarket, Here’s What Happening.

    Tonix Pharmaceuticals Holding Corp. (TNXP) is a biotherapeutics company engaged in the discovery, licensing, acquisition, and development of therapeutics for different diseases. The company’s product pipeline consists of TNX-1800 as a COVID-19 vaccine. TNX-3500 and TNX-102 SL are under the clinical stage for treating COVID-19. TNX-102 SL is the company’s CNS candidate in Phase 3 trials for treating fibromyalgia. TNX-1300 is used to treat cocaine intoxication.

    The price of TNXP stock during the regular trading on February 7, 2022, was $0.23 with an incline of 6.65%. At last check in the premarket on February 8, 2022, the stock dropped by 3.87%.

    TNXP: Events and Happenings

    On February 07, 2022, New to the Street TV updated about interviewing TNXP’s CEO Seth Lederman on the same date. The host and guest discussed the company’s Covid-19 vaccine, antiviral pharmaceutical, and COVID-related innovative product line.  On February 07, 2022, TNXP was informed about attending the Virtual BIO CEO & Investor Conference by its Executive management. The conference will be held on February 14-17, 2022.

    On January 11, 2022, TNXP reported about the preliminary patient enrollment in the dose-finding trials for TNX-2100. It is used to measure delayed-type hypersensitivity (DTH) to CoV-2. On January 05, 2022, TNXP announced that the Executive management of the company participated in the following conferences.

    • Virtual H.C. Wainwright BioConnect Conference on January 10-13, 2022.
    • The Virtual Biotech Showcase 2022 was held on January 10-12, 2022.

    On January 04, 2022, TNXP was informed about the research partnership and options contract with Kansas State University. Both parties agreed upon the development of zinc nanoparticle mRNA vaccines to replace the lipid-nanoparticle technology. The ZNP technology conferred augmented stability to mRNA vaccination over a wide temperature range. On December 15, 2021, TNXP was added to the Nasdaq Biotechnology Index with effect from December 20, 2021.

    TNXP: Key Financials

    On November 8, 2021, TNXP released its financial results for the third quarter of 2021 ended September 30, 2021. Some of the key highlights are mentioned below.

    Assets

    Total current assets in Q3 2021 were recorded to be $195 million.

    EPS

    Basic and diluted net loss per share in Q3 2021 was $18.5 million or $0.05 compared to $11.9 million, or $0.09 in the same period of 2020. The company’s EPS beat the analyst’s estimate by $0.02.

    Conclusion

    TNXP’s stock downplayed by 66% from the last six months period due to financial restrains by the pandemic. The company’s stock declined in the current premarket despite the fact that the company announced a special stockholders meeting and its interview being featured on the New to the Street TV. As TNXP is approaching its earning release date, the analysts are predicting the current quarter’s EPS to be -$0.05.

  • What changed for these 46 stocks in Pre Market Session?

    What changed for these 46 stocks in Pre Market Session?

    Alterity Therapeutics Limited (ATHE) stock plunged -10.31% to $2.0 in the pre-market trading after the company announced the approval of a US patent for the next generation.

    Cinedigm Corp. (NASDAQ: CIDM) shares are trading down -4.55% at $0.525 at the time of writing after it posted Second Quarter Fiscal 2021 Earnings. The company’s 52-week range was noted as $0.25 to $6.00. Analysts have a consensus price target of $3.50.

    iBio Inc. (IBIO) tumbled over -2.34% at $1.67 in pre-market trading today as the Company revealed fiscal first quarter 2021 Financial results and provides a business update.

    CBAK Energy Technology Inc. (CBAT), an Electrical Equipment & Parts company, dropped about -7.4% at $9.01 in pre-market trading Wednesday.

    Comstock Mining Inc. (LODE) stock moved down -1.96 percent to $1.0 in the pre-market trading as it revealed to Host Earnings Call.

    CureVac N.V. (CVAC) lost over -3.01% at $74.19 in pre-market trading Wednesday 18 November 2020 after the news that the Company has established a European-based network to ramp Up manufacturing of its COVID-19 vaccine candidate, CVnCoV.

    Oncternal Therapeutics Inc. (ONCT) is down more than -24.88% at $3.11 in pre-market hours Wednesday 18 November 2020 as the Company increases previously revealed bought deal to $22.5 million. The stock had dropped over -9.41% to $4.14 in the last trading session.

    Before the trading started on 18 November 2020, New Concept Energy Inc. (GBR) is down -11.38% to reach $1.48 after the firm announced its Q3, 2020 results. It has been trading in a 52-week range of $0.55 to $2.19.

    Polar Power Inc. (POLA) stock plunged -7.25% to $3.07 in the pre-market trading. The most recent rating by ROTH Capital, on November 07, 2017, is at a Neutral.

    Trinity Biotech plc (NASDAQ: TRIB) shares are trading down 0.0% at $2.9 at the time of writing. The company’s 52-week range was noted as $0.56 to $3.35 as the company set to Host an Earnings Call.

    So-Young International Inc. (SY) grew over 4.65% at $13.5 in pre-market trading today as the company said it is going to report its earnings to result on November 25, 2020.

    BioNTech SE (BNTX), a Biotechnology company, rose about 4.22% at $90.6 in pre-market trading Wednesday after the report that Pfizer and BioNTech planned to file as vaccine proves 95% effective.

    Sunworks Inc. (SUNW) stock moved down -4.91 percent to $3.68 in the pre-market trading after the Company revealed that the proposed merger with the Peck Company Holdings, Inc. failed to secure stockholder approval.

    Sundial Growers Inc. (SNDL) lost over -3.04% at $0.2424 in pre-market trading Wednesday 18 November 2020 following the announcement of its third-quarter earnings results.

    Tuniu Corporation (TOUR) is up more than 1.04% at $1.95 in pre-market hours Wednesday 18 November 2020. The stock had dropped over -3.98% to $1.93 in the last trading session.

    Before the trading started on 18 November 2020, Taiwan Semiconductor Manufacturing Company Limited (TSM) is up 3.22% to reach $98.79 following the report that Samsung heats up chip wars with the claim that it can catch TSMC by 2022. It has been trading in a 52-week range of $42.70 to $102.44.

    Hill International Inc. (HIL) stock plunged -5.49% to $1.55 in the pre-market trading as the company said that CEO Raouf Ghali and CFO Todd Weintraub are scheduled to present at the following investor conferences during the month of November.

    Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares are trading down -4.77% at $0.5615 at the time of writing after the preliminary results following vaccination of non-human primates with TNX-1800 a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 spike protein after vaccination. The company’s 52-week range was noted as $0.39 to $2.46. Analysts have a consensus price target of $4.

    Genius Brands International Inc. (GNUS) tumbled over -3.42% at $1.13 in pre-market trading today after the company revealed strategic takeover of ChizComm Ltd. and ChizComm Beacon Media.

    Medley Management Inc. (MDLY), an Asset Management company, rose about 33.73% at $9.0 in pre-market trading Wednesday announced third-quarter earnings results.

    China SXT Pharmaceuticals Inc. (SXTC) stock moved down -3.59 percent to $0.2603 in the pre-market trading.

    Camtek Ltd. (CAMT) lost over -3.64% at $19.05 in pre-market trading Wednesday 18 November 2020 following the news of the commencement of a proposed underwritten public offering of three million ordinary shares.

    Cellectis S.A. (CLLS) is up more than 5.58% at $20.8 in pre-market hours Wednesday 18 November 2020, after the firm announced the appointment of Kyung Nam-Wortman as Cellectis’ Executive Vice President, Chief Human Resources Officer. The stock had dropped over -1.79% to $19.70 in the last trading session.

    Before the trading started on 18 November 2020, TechnipFMC plc (FTI) is up 4.34% to reach $8.42 after the Company received notice to proceed with the EPC contract for Sempra LNG’s and IEnova’s Energía Costa Azul LNG facility. It has been trading in a 52-week range of $4.49 to $21.84.

    Li Auto Inc. (LI) stock soared 3.17% to $36.16 in the pre-market trading after the Company revealed the 3rd quarter of 2020 Earnings results. The most recent rating by Citigroup, on November 16, 2020, is at a Buy.

    BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) shares are trading down -2.47% at $2.76 at the time of writing. The company’s 52-week range was noted as $2.35 to $62.00.

    Neptune Wellness Solutions Inc. (NEPT) tumbled over -2.63% at $1.85 in pre-market trading today after the company posted 2nd quarter loss and missed the predictions.

    Livent Corporation (LTHM), a Specialty Chemicals company, rose about 4.19% at $15.9 in pre-market trading Wednesday following the report of Analysts revised their forecast after disappointing Earnings.

    Micro Focus International plc (MFGP) stock moved up 29.73 percent to $4.8 in the pre-market trading.

    Houghton Mifflin Harcourt Company (HMHC) gained over 5.63% at $3.0 in pre-market trading Wednesday 18 November 2020 after the Company announced financial results for the quarter ended September 30, 2020. The Company revealed its plan to explore the potential sale of HMH Books & Media, its Consumer Publishing business.

    Acasti Pharma Inc. (ACST) is up more than 3.81% at $0.218 in pre-market hours Wednesday 18 November 2020 as the Company offered a business update for Q2, 2020. The stock had jumped over 0.77% to $0.21 in the last trading session.

    Before the trading started on 18 November 2020, Canaan Inc. (CAN) is up 8.73% to reach $3.61. It has been trading in a 52-week range of $1.76 to $13.00.

    VAALCO Energy Inc. (EGY) stock soared 45.1% to $1.48 in pre-market trading.

    Liminal BioSciences Inc. (NASDAQ: LMNL) shares are trading up 11.37% at $4.31 at the time of writing posted third-quarter results. The company’s 52-week range was noted as $3.51 to $31.45.

    Carver Bancorp Inc. (CARV) grew over 3.89% at $6.95 in pre-market trading today.

    Vaxart Inc. (VXRT), a Biotechnology company, dropped about -2.47% at $5.53 in pre-market trading Wednesday after it publicized that it is set to host a Key Opinion Leader (KOL) panel for investors entitled “An Oral Tablet Vaccine – A Potential Global Solution to COVID-19 and Norovirus?” on Thursday, November 19, 2020, at 12pm Eastern Time.

    SCWorx Corp. (WORX) stock moved down -3.64 percent to $1.06 in the pre-market trading.

    Sunoco LP (SUN) lost over -7.0% at $27.11 in pre-market trading Wednesday 18 November 2020 as the Company gained above 5% as Q3 Earnings topped predictions.

    NIO Limited (NIO) is up more than 3.78% at $48.35 in pre-market hours Wednesday 18 November 2020 as the Company revealed its Q3 loss less than expected, whiles sales topped predictions. The stock had jumped over 2.22% to $46.59 in the last trading session.

    Before the trading started on 18 November 2020, Ocugen Inc. (OCGN) is up 4.27% to reach $0.3029 as Company recently revealed Q3 results. It has been trading in a 52-week range of $0.17 to $0.96.

    Weidai Ltd. (WEI) stock soared 9.4% to $1.63 in the pre-market trading after the report that the Company regained compliance after receipt of NYSE Non-compliance letter regarding ADS trading price on October 20, 2020. The most recent rating by Morgan Stanley, on January 21, 2020, is at an Underweight.

    Magnolia Oil & Gas Corporation (NYSE: MGY) shares are trading up 2.99% at $6.2 at the time of writing after the Company missed Earnings predictions. The company’s 52-week range was noted as $3.23 to $13.28.

    Waitr Holdings Inc. (WTRH) grew over 13.68% at $3.24 in pre-market trading today as the Company beat the Earnings outlook.

    Norwegian Cruise Line Holdings Ltd. (NCLH), a Travel Services company, dropped about -6.17% at $20.7 in pre-market trading Wednesday after the company revealed the pricing of 40,000,000 ordinary shares.

    IZEA Worldwide Inc. (IZEA) stock moved up 5.49 percent to $0.77 in the pre-market trading as it revealed Q3 financial results.

    The Boeing Company (BA) gained over 3.53% at $217.46 in pre-market trading Wednesday 18 November 2020 after the report that Boeing’s 737 Max cleared to fly in the US after crashes.